Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.

Clinical trials sponsored by Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a new formulation of an endometriosis drug match the standard? Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

Can a new formulation of an endometriosis drug match the standard?

Disease control Recruiting now

This trial compares HHK001, an investigational version of leuprorelin acetate, to Enantone, an approved treatment for endometriosis. Both contain the same active ingredient, but HHK001 uses an updated formulation. The study will enroll 30 women aged 18-45 with endometriosis, who …

Phase 1 • Sponsor: Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd. • Aim: Disease control

Last updated Sep 04, 2026 00:00 UTC